GRPR and prostate cancer: However, few examples of GRPR-targeted delivery strategies have been reported for other anticancer drugs (e.g., doxorubicin, paclitaxel, and docetaxel), based mainly on liposomes and polymeric nanoparticles to treat NSCL and prostate cancers 36, 37.